Vaxart, Inc. VXRT
Nov 9, 2026, 1:54 PM EST
- YTD
- +5.71%
- 1 year
- -2.63%
Discussion (1070)
Sign in to join the discussion
All walls will be broken at open....insane volume ?
There are ZERO shares to short, and conference coming this evening. This can easily go upto $20 and if WSB are here, we can see a squeeze to $50!
This will run crazy today...watch $15 coming ??
$VXRT ?????Opening tomorrow @15 IMHO. ?????
Tomorrow would a nice short squeeze. We might see $12+??
Tomorrow we will see huge gap up...$10 is nothing for such a promising pill, which has better results than Moderna and Pfizer. Buy/Hold and enjoy your gains ????
Just came in the India news :
Serum, Bharat Biotech got advance of Rs 2,500 crore for 16 crore doses, says government
Rupali Mukherjee / TNN / May 4, 2021, 02:18 IST
MUMBAI: The government on Monday said it had paid an advance of over Rs 2,500 crore to Serum Institute of India and Bharat Biotech for supply of 16 crore doses of Covid vaccine between May and July.
While Serum Institute is to supply 11 crore doses of Covishield, the rest will be Covaxin manufactured by Bharat Biotech. Based on the advance paid on April 28, the price works out to a little under Rs 160 per shot.
SII CEO Adar Poonawalla had suggested that the Centre should increase the price as the company needed to boost capacity.
The government’s statement came after Poonawalla’s interview to The Financial Times, where he had suggested the company did not expand capacity due to the absence of orders. Besides, the Centre has been facing criticism for not procuring enough vaccine before opening inoculations for those over 18 years.
It said that against an earlier order of 10 crore doses, Serum had delivered 8.7 crore shots till Monday, while Bharat Biotech had delivered 88 lakh against an order of 2 crore shots. The Centre had announced last month that it is making an advance payment of around Rs 3,000 crore to Serum Institute and Rs 1,500 crore to Bharat Biotech.
The controversy also forced Poonawalla to issue a statement, saying the firm has been working closely with the government for the past year and is committed to ramping up capacity. “...it is not possible to ramp up production overnight. We also need to understand that the population of India is huge and to produce enough doses for all adults is not an easy task. Even the most advanced countries and companies are struggling in relatively smaller populations,” he said, adding he would like to clarify since his (overall) comments may have been misinterpreted.
Poonawalla said against overall orders of over 26 crore doses, Rs 15 crore had been supplied to the government. “Another 11 crore doses will be supplied in the second channel for state and private hospitals,” he said.
If they have what they say they have… the funding to LEAP to production will be nothing short of world changing.
Added 5k @9.84...can’t wait to see this fly tomorrow PM to $11 ???
I am holding my 3k shares tonight and putting sell limit at $25. I suggest don’t settle for pennies. This is a diamond stock, and will pay off BIG time!
